Compare NGVC & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NGVC | ARDX |
|---|---|---|
| Founded | 1955 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.5M | 797.8M |
| IPO Year | 2012 | 2014 |
| Metric | NGVC | ARDX |
|---|---|---|
| Price | $29.71 | $3.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $42.25 | $12.90 |
| AVG Volume (30 Days) | 102.2K | ★ 4.1M |
| Earning Date | 11-19-2026 | 11-02-2026 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | ★ 36.05 | N/A |
| EPS | ★ 1.54 | N/A |
| Revenue | N/A | ★ $2,607,000.00 |
| Revenue This Year | $2.22 | $19.98 |
| Revenue Next Year | $5.52 | $27.70 |
| P/E Ratio | $19.87 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.47 | $3.06 |
| 52 Week High | $41.07 | $8.40 |
| Indicator | NGVC | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 46.69 | 33.33 |
| Support Level | $28.22 | N/A |
| Resistance Level | $30.17 | $3.63 |
| Average True Range (ATR) | 0.86 | 0.12 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 2.20 | 17.07 |
Natural Grocers by Vitamin Cottage Inc operates natural and organic grocery and dietary supplement stores. It offers the following product categories: natural and organic food, dietary supplements, natural body care, household, pet care products, books, and handouts. The Company has a single reporting segment, natural and organic retail stores, through which business is conducted. The company generates the majority of its revenue from grocery products and dietary supplements, and the rest from other products.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.